Verapamil abolishes the preglomerular response to ANG II during intrarenal nitric oxide synthesis inhibition

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 272, Issue 5 41-5, 1997, Pages

  Schnackenberg, Christine G ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Calcium channels; Endothelium derived relaxing factor; Renal segmental resistance

Indexed keywords

ANGIOTENSIN; CALCIUM CHANNEL; ENDOTHELIUM DERIVED RELAXING FACTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0030965030     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.272.5.r1670     Document Type: Article

References (15)

1. Alberola, A. M., F. J. Salazar, and J. P. Granger. Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R1472-R1478, 1994.
2. Carmines, P. K., and L. G. Navar. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F1015-F1020, 1989.
3. Cauvin, C., R. Loutzenhiser, and C. Van Breeman. Mechanism of calcium antagonist-induced vasodilation. Annu. Rev. Pharmacol. Toxicol. 23: 373-396, 1983.
4. Chevalier, R. L., B. A. Thornhill, and R. A. Navar. EDRF modulates renal hemodynamics during unilateral ureteral obstruction in rat. Kidney Int. 42: 400-406, 1992.
5. Church, J., and T. T. Zsoter. Calcium antagonistic drugs. Mechanism of action. Can. J. Physiol. Pharmacol. 58: 254-264, 1980.
6. 2+ antagonists and calmodulin inhibitors. Circ. Res. 56: 97-108, 1985.
7. Dietz, J. R., J. O. Davis, R. H. Freeman, D. Villarreal, and S. F. Echtenkamp. Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs. Hypertension 5: 482-488, 1983.
8. Fleckenstein, A. Calcium Antagonism in Heart, and Smooth Muscle: Experimental Facts and Therapeutic Prospects. New York: Wiley, 1983, p. 224-267.
9. Goligorsky, M., S. D. Colflesh, D. Gordienko, and L. C. Moore. Branching points of renal resistance arteries are enriched in L-type calcium channels and initiate vasoconstriction. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F251-F257, 1995.
10. Granger, J. P., and M. J. Solhaug. Renal interstitial hydrostatic pressure during verapamil-induced natriuresis. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31): R432-R436, 1992.
11. Hall, J. E., T. G. Coleman, A. C. Guyton, P. R. Kastner, and J. P. Granger. Control of glomerular filtration rate by circulating angiotensin II. Am. J. Physiol. 241 (Regulatory Integrative Comp. Physiol. 10): R190-R197, 1981.
12. Hall, J. E., and J. P. Granger. Renal hemodynamic actions of angiotensin II: interaction with tubuloglomerular feedback. Am. J. Physiol. 245 (Regulatory Integrative Comp. Physiol. 14): R166-R173, 1983.
13. Hall, J. E., A. C. Guyton, and A. W. Cowley, Jr. Dissociation of renal blood flow and filtration rate autoregulation by renin depletion. Am. J. Physiol. 232 (Renal Fluid Electrolyte Physiol. 1): F215-F221, 1977.
14. Hall, J. E., A. C. Guyton, T. E. Jackson, T. G. Coleman, T. E. Lohmeier, and N. C. Tripdo. Control of glomerular filtration rate by the renin-angiotensin system. Am. J. Physiol. 233 (Renal Fluid Electrolyte Physiol. 2): F366-F372, 1977.
15. Ichikawa, I., J. F. Miele, and B. M. Brenner. Reversal of renal cortical actions of angiotensin II by verapamil and manganese. Kidney Int. 16: 137-147, 1979.